Fig. 2.
Biomarker change in response to Regorafenib and PF-03446962. a Early changes during cycle 1 of therapy and b late changes during cycle 2 of therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.